Filing Details

Accession Number:
0000950170-24-068141
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-03 17:37:54
Reporting Period:
2024-05-31
Accepted Time:
2024-06-03 17:37:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1029142 Dynavax Technologies Corp DVAX Pharmaceutical Preparations (2834) 330728374
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1286710 Francis Cano C/O Dynavax Technologies
2100 Powell Street, Suite 720
Emeryville CA 94608
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-05-31 3,615 $11.93 36,905 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct